Abstract

The two most commonly used methods for the determination of a virus potency are plaque assay and 50% cell culture infective dose (CCID 50) assay, both based on cytopathic effect observation. We compared the potency estimates obtained by plaque and CCID 50 assays for nine mumps virus strains that produce different cytopathic effects in Vero cells. The ratios of CCID 50 and plaque assay quantification results differed for different strains and were in a range of 0.66–10, indicating that quantification results for some mumps virus strains are almost identical regardless of whether CCID 50 or plaque method is used, while the potency estimates of other strains strongly depend on the choice of the assay.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.